Analystreport
Coherus Biosciences Inc (NASDAQ: CHRS) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
Last coherus biosciences earnings: 11/6 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com
IMPACT SNAPSHOT | EVENT TIME: | CHRS | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
CHRS alerts
CHRS alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
CHRS alerts
High impacting COHERUS BIOSCIENCES news events
Weekly update
A roundup of the hottest topics
CHRS
NEWS
NEWS
- Coherus BioSciences (NASDAQ: CHRS) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating.[MarketBeat]
- Coherus BioSciences Announces New Employment Inducement Grants[GlobeNewswire]
- Coherus BioSciences (NASDAQ: CHRS) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating.[MarketBeat]
- Coherus BioSciences Management to Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco[GlobeNewswire]
- BRIEF-Coherus Biosciences Says U.S. Court Grants Motion To Dismiss Patent Infringement Complaint [Reuters][Reuters]
- More
CHRS
SEC Filings
SEC Filings
- 4/13/18 - Form DEFA14A
- 4/13/18 - Form DEF
- 3/26/18 - Form 8-K
- CHRS's page on the SEC website
- More